insights_auto
Why is LLY down 3,78%?
Dive Deeperchevron_right
LLY:NYSE
Eli Lilly And Co
1 364,73 $
arrow_downward
-3,78%(-53,58) 1D
1 365,00 $
arrow_upward
+0,02% (+0,27)bedtimeAfter hours
Closed: 5 қар., 16:04:36 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
1 434,00 $
High
1 453,00 $
Low
1 364,73 $
Mkt. cap
1,28 трлн
Avg. vol.
2,55 млн
Volume
3,90 млн
Dividend
0,51%
Quarterly dividend
1,73 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
44,30
52-wk high
1 453,00 $
52-wk low
850,51 $
EPS
30,81 $
Beta
0,40
Shares outstanding
940,74 млн
No. of employees
50 мың
Open
1 434,00 $
High
1 453,00 $
Low
1 364,73 $
Mkt. cap
1,28 трлн
Avg. vol.
2,55 млн
Volume
3,90 млн
Dividend
0,51%
Quarterly dividend
1,73 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
44,30
52-wk high
1 453,00 $
52-wk low
850,51 $
EPS
30,81 $
Beta
0,40
Shares outstanding
940,74 млн
No. of employees
50 мың
News stories
From web sources and news partners
Zacks
·
2 сағат бұрын
4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally
Yahoo Finance
·
3 сағат бұрын
4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally
The Globe and Mail
·
3 сағат бұрын
2 Growth Stocks to Buy in November Without Any Hesitation
Investing.com
·
6 сағат бұрын
Eli Lilly stock hits all-time high at 1449.78 USD
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees50 мың
Founded1876
HeadquartersИндианаполис, Индиана, Америка Құрама Штаттары
SectorHealth Care
IndustryPharmaceutical industry
Websitelilly.com